Mark A. Douglas was appointed as Chairman of the Board at QUAKER CHEMICAL CORP.
“the Board appointed Mr. Mark A. Douglas, an independent director who has served on the Board since 2013, to succeed Mr. Barry as Chairman.”
QUAKER CHEMICAL CORP — fact timeline
Source-grounded facts extracted from QUAKER CHEMICAL CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Michael F. Barry retired as Chairman of the Board at QUAKER CHEMICAL CORP.
“Mr. Michael F. Barry, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”) notified the Company of his retirement from the Board, effective at the conclusion of the Board meeting on May 13, 2026.”
QUAKER CHEMICAL CORP reported first quarter ended March 31, 2026 results: revenue $480.5 million, net income $19.7 million, EPS $1.13.
“• Q1’26 net sales of $480.5 million , an increase of 8% Y/Y, net income of $19.7 million and earnings per diluted share of $1.13”
QUAKER CHEMICAL CORP incurred revolving credit of $800,000,000 with Bank of America, N.A. at Term SOFR plus Applicable Rate ranging from 1.000% to 1.750% for Term SOFR Loans maturing April 10, 2031.
“(the " New U.S. Term Facility ") and (C) a new senior secured revolving credit facility for the Company and certain designated subsidiaries in an aggregate principal amount of $800,000,000 (the “ New Revolving Credit Facility ”), (ii) use the proceeds of the New Term Facilities and borrowings under the New Revolving Credit Facility to repay in full all outstanding”
QUAKER CHEMICAL CORP incurred credit facility of $550,000,000 with Bank of America, N.A. at Term SOFR plus Applicable Rate ranging from 1.000% to 1.750% for Term SOFR Loans maturing April 10, 2031.
“to $250,000,000 (the “ New Euro Term Facility ”), (B) a new senior secured U.S. dollar-denominated term loan facility for the Company in an aggregate principal amount of $550,000,000 (the " New U.S. Term Facility ") and (C) a new senior secured revolving credit facility for the Company and certain designated subsidiaries in an aggregate principal amount of”
QUAKER CHEMICAL CORP incurred credit facility of $250,000,000 equivalent in Euros with Bank of America, N.A. at Alternative Currency Term Rate plus Applicable Rate ranging from 1.000% to 1.750 maturing April 10, 2031.
“(A) a new senior secured euro-denominated term loan facility for Quaker Houghton B.V. in an aggregate principal amount equal to the amount in Euros that is equivalent to $250,000,000 (the “ New Euro Term Facility ”), (B) a new senior secured U.S. dollar-denominated term loan facility for the Company in an aggregate principal amount of $550,000,000 (the " New”
QUAKER CHEMICAL CORP amended Amendment No. 4 with Bank of America, N.A., as administrative agent, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders valued at $250,000,000 (effective 2026-04-10).
“On April 10, 2026, Quaker Chemical Corporation (the “ Company ”), and its wholly-owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer (the “ Administrative Agent ”), Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders (the “ Lenders ”) entered into Amendment No. 4 (the “ Amended Credit Agreement ”) to its existing credit agreement”
Ramaswami Seshasayee retired as Director at QUAKER CHEMICAL CORP.
“On May 14, 2025, Mr. Ramaswami Seshasayee, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (“the Company”) notified the Company of his retirement from the Board, effective on such date.”
Andrew E. Tometich departed as Chief Executive Officer and President at QUAKER CHEMICAL CORP.
“Additionally, effective as of November 18, 2024, Andrew E. Tometich no longer serves as the Company’s Chief Executive Officer and President or as a member of the Board.”
Joseph A. Berquist was appointed as Chief Executive Officer and President at QUAKER CHEMICAL CORP.
“On November 14, 2024, the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”), appointed Joseph A. Berquist, age 53, the Company’s Chief Commercial Officer, to serve as Chief Executive Officer and President, effective November 18, 2024.”
Lucrèce Foufopoulos-De Ridder was elected as Director at QUAKER CHEMICAL CORP.
“elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.”
Nandita Bakhshi was elected as Director at QUAKER CHEMICAL CORP.
“elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.”
QUAKER CHEMICAL CORP shareholders approved Ratification of Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for Fiscal Year 2024.
“Proposal No. 4 – Ratification of Appointment of Independent Registered Public Accounting Firm for Fiscal Year 2024 The shareholders voted to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year 2024. The results of the vote were as follows: For Against Abstain 16,772,663 248,384 19,281 2”
QUAKER CHEMICAL CORP shareholders approved Approval of the Quaker Houghton 2024 Long-Term Performance Incentive Plan.
“Proposal No. 3 – Approval of the Quaker Houghton 2024 Long-Term Performance Incentive Plan The Company’s shareholders approved the Restated Plan. The results of the vote were as follows: For Against Abstain Broker Non-Votes 12,844,880 3,301,645 446,345 447,458”
QUAKER CHEMICAL CORP shareholders approved Advisory Vote on Compensation of the Company's Named Executive Officers.
“Proposal No. 2 – Advisory Vote on Compensation of the Company’s Named Executive Officers The Company’s shareholders approved, on a non-binding basis, the Company’s compensation of its named executive officers as described in the Compensation Discussion and Analysis section and the accompanying compensation tables and narrative disclosures contained in the Company’s Proxy Statement for the 2024 Annual Meeting (the “2024 Proxy Statement”). The results of the vote were as follows: For Against Abstain Broker Non-Votes 16,103,454 446,002 43,414 447,458”
QUAKER CHEMICAL CORP shareholders approved Election of three directors to serve a three-year term until the 2027 annual meeting.
“Proposal No.1 – Election of Directors. The shareholders elected three directors to serve a three-year term until the 2027 annual meeting of shareholders and until their respective successors are duly elected and qualified. The results of the vote were as follows: Directors For Against Abstain Broker Non-Votes Michael F. Barry 15,465,074 1,105,533 22,263 447,458 Jeffry D. Frisby 15,125,665 1,438,118 29,087 447,458 Russell R. Shaller 15,948,517 598,302 46,051 447,458”
Tom Coler was appointed as Executive Vice President and Chief Financial Officer at QUAKER CHEMICAL CORP.
“On May 6, 2024, the Board of Directors of the Company appointed Tom Coler, age 50, to Executive Vice President and Chief Financial Officer, effective June 10, 2024.”
Shane Hostetter was terminated as Chief Financial Officer at QUAKER CHEMICAL CORP.
“On May 9, 2024, Quaker Chemical Corporation (the “Company”) announced the termination of the employment of Shane Hostetter, as the Company’s Chief Financial Officer, effective as of June 7, 2024.”
QUAKER CHEMICAL CORP reported the first quarter ended March 31, 2024 results: revenue $469.8 million, net income $35.2 million, EPS $1.95.
“Vice President, Investor Relations investor@quakerhoughton.com T. 1.610.832.4087 For Release: Immediate QUAKER HOUGHTON ANNOUNCES FIRST QUARTER 2024 RESULTS • Q1’24 net sales of $469.8 million , net income of $35.2 million and earnings per diluted share of $1.95 • Q1’24 non-GAAP net income of $37.7 million and non-GAAP earnings per diluted share of $2.09 • Delivered”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.